JPC - Journal of Planar Chromatography - Modern TLC
Volume/Issue:
Volume 31: Issue 4
Validated stability-indicating high-performance liquid chromatography and thin-layer chromatography methods for the determination of zopiclone in pharmaceutical formulation
Authors:
Sawsan A. Abdel Razeq Al-Azhar University, Cairo, Egypt

Search for other papers by Sawsan A. Abdel Razeq in
Current site
Google Scholar
PubMed Close
,
Suzan M. Soliman National Organization for Drug Control and Research (NODCAR), Giza, Egypt

Search for other papers by Suzan M. Soliman in
Current site
Google Scholar
PubMed Close
, and
Amal S. Mohamed National Organization for Drug Control and Research (NODCAR), Giza, Egypt

Search for other papers by Amal S. Mohamed in
Current site
Google Scholar
PubMed Close
Pages:
297–308
Online Publication Date:
Aug 2018
Publication Date:
01 Aug 2018
Article Category:
Research Article
DOI:
https://doi.org/10.1556/1006.2018.31.4.5
Keywords:
Zopiclone; Stability-indicating assay; High-performance liquid chromatography; Thin-layer chromatography–densitometry; IR and mass spectrometry; Degradation pathway
Restricted access

Two novel, sensitive, and selective stability-indicating chromatographic methods were described for the analysis of zopiclone (ZOP) in the presence of its degradation products, namely, 7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate (hydrolytic DEG) and 5H-pyrrolo[3,4-b]pyrazine-5,7(6H)-dione (oxidative DEG), in drug substance and product. The first method was an isocratic reversed-phase high-performance liquid chromatography (RP-HPLC) using Inertsil ODS3 (250 × 4 mm, 5 μm) column. Upon using HPLC, the run time could be reduced, and actually, the solvents consumption decreased. Quantification was achieved by detection wavelength at 237 nm, based on peak area. Chromatographic separation was performed over the range of 1–10 μg mL−1 with limits of detection (LOD) and quantification (LOQ) of 0.18 and 0.55 μg mL−1 and a mean recovery of 99.98 ± 0.55. The analysis was achieved at 30°C using a mixture of acetonitrile and water (50:50 v/v) as the mobile phase. The second method was thin-layer chromatography (TLC) applied for the separation and analysis of zopiclone in the presence of its alkaline, acidic, and oxidative degradation products. Chromatography was performed on silica gel 60 F254 plates with ethyl acetate‒methanol‒ammonia 33% (17:2:1 v/v) as the mobile phase. Successful resolution was observed with significant difference in the RF values, followed by densitometric measurement at 303 nm. Evaluation was carried out over the range of 0.1–2 μg per spot with a mean recovery of 100.52% ± 0.24. The developed methods were successfully applied to the analysis of ZOP in bulk powder, laboratory-prepared mixtures containing different percentages of its degradation products, and pharmaceutical dosage form. The degradation products were separated by HPLC as well as identified by TLC, infrared (IR), and mass spectrometry (MS) to confirm its structures and elucidate degradation pathway. The developed methods were validated as per the International Conference on Harmonization (ICH) guidelines. The results obtained by the proposed methods were statistically compared with the reported methods revealing high accuracy and good precision.

  • [1]

    S.C. Sweetman , Martindale: The Complete Drug Reference, 38th edn., The Pharmaceutical Press, London, 2014, pp. 109.

  • [2]

    Merck Research Laboratories, Division of Merck & Co. Inc., Merck Index, 13th edn., Whitehouse Station, NJ, 2001.

  • [3]

    The British Pharmacopeia, Vol. 2, Her Majesty’s Stationery Office, London, 2016.

  • [4]

    S. Yılmaz , Colloids Surf. B 71 (2009) 79–83.

  • [5]

    A. Bouklouze , J.C. Viré, G.C. Quarin, J.M. Kauffmann, Electroanalysis 6 (1994) 1045–1050.

  • [6]

    J.C. Viré , H. Zhang, G. Quarin, G.J. Patriarche, Z. Sentürk, G.D. Christian, Talanta 40 (1993) 313–323.

  • [7]

    A.S. Al-Attas , J.J. Nasr, S. Shalan, F. Belal, Spectrochim. Acta A 181 (2017) 148–152.

  • [8]

    M.M. Abdelrahman , I.A. Naguib, M.R. El Ghobashy, N.A. Ali, Spectrochim. Acta A 137 (2015) 617–624.

  • [9]

    B. Paw , G. Misztal, J. Pharm. Biomed. Anal. 23 (2000) 819–823.

  • [10]

    T.P. Rohrig , M.C. Norton, L.A. Harryman, Methods Mol. Biol. 603 (2010) 527–533.

  • [11]

    J. Van Bocxlaer , E. Meyer, K. Clauwaert, W. Lambert, M. Piette, A. De Leenheer, J. Anal. Toxicol. 20 (1996) 52–54.

  • [12]

    I.A. Naguib , M.M. Abdelrahman, M.R. El Ghobashy, N.A. Ali, Chromatogr. Sci. 53 (2015)1395–1399.

  • [13]

    P. Pushpalatha , R.K. Sarin, M.A. Rao, T.R.R. Baggi, J. Planar Chromatogr. 22 (2009) 449–451.

  • [14]

    I. Chopra , J. Kaur, D.K. Yadav, M. Hasan, P.K. Tyagi, B. Kumar, Int. J. Pharm. Sci. Res. 6 (2015) 2876–2881.

  • [15]

    S. Sangaraju , M. Lakshmi Kanth, B.M. Rao, N. Someswararao, Pharmazie 64 (2009) 717–719.

  • [16]

    M.V. Basaveswara Rao , A.V.D. Nagendrakumar, M. Sivanadh, P.V. Ramhachari, J. Pharm. Res. 4 (2011) 248–249.

  • [17]

    H.N. Mistri , A.G. Jangid, A. Pudage, P. Shrivastav, J. Chromatogr. B 864 (2008) 137–148.

  • [18]

    G.H. Nilsson , F.C. Kugelberg, J. Ahlner, R. Kronstrand, Int. J. Legal Med. 129 (2015) 269–77.

  • [19]

    G.H. Nilsson , F.C. Kugelberg, J. Ahlner, R. Kronstrand, J. Anal. Toxicol. 38 (2014) 327–334.

  • [20]

    R. El-Shaheny , A. Alattasb, J.J. Nasra, N. El-Enanya, F. Belal, J. Chromatogr. B 907 (2012) 49–55.

  • [21]

    E. Mannaert , J. Tytgat, P. Daenens, J. Anal. Toxicol. 21 (1997) 208–212.

  • [22]

    J.P. Bounine , B. Tardif, P. Beltran, D.J. Mazzo, J. Chromatogr. A 677 (1994) 87–93.

  • [23]

    ICH Q1A (R2), Stability Testing of New Drug Substances and Products, International Conferences on Harmonisation Guidelines, Geneva, 2000.

  • [24]

    S. Görög , Trends Anal. Chem. 26 (2017) 12–17.

  • [25]

    P.D. Sethi , High Performance Thin Layer Chromatography, Quantitative Analysis of Pharmaceutical Formulations, BS Publication and Distributors, New Delhi, 1996.

    • Search Google Scholar
    • Export Citation
  • [26]

    ICH Guideline Q2 (R1), Validation of Analytical Procedures: Text and Methodology, International Conferences on Harmonisation Guidelines, Geneva, 2005.

  • Collapse
  • Expand
Cover JPC - Journal of Planar Chromatography - Modern TLC
JPC - Journal of Planar Chromatography - Modern TLC
Print ISSN:
0933-4173
Online ISSN:
1789-0993

To see the editorial board, please visit the website of Springer Nature.

Manuscript Submission: HERE

For subscription options, please visit the website of Springer Nature.

Journal of Planar Chromatography - Modern TLC
Language English
Size A4
Year of
Foundation		 1988
Volumes
per Year		 1
Issues
per Year		 6
Founder Akadémiai Kiadó
Founder's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 0933-4173 (Print)
ISSN 1789-0993 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Aug 2024 45 0 0
Sep 2024 60 0 0
Oct 2024 154 0 0
Nov 2024 122 0 0
Dec 2024 159 0 0
Jan 2025 26 0 0
Feb 2025 0 0 0